GSK PLC (GLAXF)
Clinical trial NCT07704892 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-20 → 2026-07-22 3. completion date: 2033-12-06 → 2033-12-08 4. primary completion date: 2030-10-14 → 2030-10-16
Clinical trial NCT07704892 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-20 → 2026-07-22 3. completion date: 2033-12-06 → 2033-12-08 4. primary completion date: 2030-10-14 → 2030-10-16
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical